PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
2024-04-24 1:46:24 PM
|
Chg.
0.00
|
Volume |
Bid8:47:54 PM |
Ask8:47:54 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
22.20EUR
|
0.00%
|
390
Turnover: 8,658 |
21.80Bid Size: 60 |
22.40Ask Size: 50 |
268.8 mill.EUR |
2.01% |
25.17 |
Fundamentals
| |
FY 2021 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
0.89 EUR |
0.00% |
| EPS Diluted: |
0.89 EUR |
0.00% |
| Revenues per Share: |
5.44 EUR |
3.32% |
| Book Value per Share: |
1.85 EUR |
92.90% |
| Cash Flow per Share: |
1.02 EUR |
-21.29% |
| Dividend per Share: |
0.45 EUR |
- |
| Total |
in mill. |
|
| Revenues: |
65.30 EUR |
3.32% |
| Net Income: |
10.70 EUR |
0.94% |
| Operating Cash Flow: |
12.20 EUR |
- |
| Cash and Cash Equivalents: |
20.80 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
25.17 |
27.87 |
| P/S Ratio: |
4.12 |
4.56 |
| P/BV ratio: |
12.11 |
13.41 |
| P/CF Ratio: |
22.03 |
24.39 |
| PEG: |
- |
- |
| Earnings Yield: |
3.97% |
3.59% |
| Dividend Yield: |
2.01% |
1.81% |
| Market Capitalization |
|
| Market Capitalization: |
268.8 mill. EUR |
297.6 mill. EUR |
| Free Float Market Cap.: |
39.86 mill. EUR |
44.13 mill. EUR |
| Market Cap. / Employee: |
3.58 mill. EUR |
3.97 mill. EUR |
| Shares Outstanding: |
12 mill. |
|
Profitability
| Gross Profit Margin: |
82.87% |
| EBIT Margin: |
22.82% |
| Net Profit Margin: |
16.39% |
| Return on Equity: |
48.20% |
| Return on Assets: |
9.28% |
Financial Strength
| Liquidity I / Cash Ratio: |
22.44% |
| Liquidity II / Quick Ratio: |
22.44% |
| Liquidity III / Current Ratio: |
35.06% |
| Debt / Equity Ratio: |
419.44% |
| Dynam. Debt / Equity Ratio: |
763.14% |
Efficiency
| Employees: |
75 |
| Personal Expenses / Employee: |
62,520.00 EUR |
| Revenues / Employee: |
870,666.67 EUR |
| Net Income / Employee: |
142,666.67 EUR |
| Total Assets / Employee: |
1,537,333.33 EUR |
| * Fiscal Year End: |
2021-12-31 |
| Accounting Standard: |
IFRS |
